Works matching IS 00126667 AND DT 2021 AND VI 81 AND IP 2

Results: 11

Vedolizumab and Extraintestinal Manifestations in Inflammatory Bowel Disease.
Published in:
Drugs, 2021, v. 81, n. 2, p. 333, doi. 10.1007/s40265-020-01460-3
By:
- Hanzel, Jurij;
- Ma, Christopher;
- Casteele, Niels Vande;
- Khanna, Reena;
- Jairath, Vipul;
- Feagan, Brian G.
Publication type:
Article
Correction to: Filgotinib: First Approval.
Published in:
Drugs, 2021, v. 81, n. 2, p. 297, doi. 10.1007/s40265-021-01468-3
By:
- Dhillon, Sohita;
- Keam, Susan J.
Publication type:
Article
Naxitamab: First Approval.
Published in:
Drugs, 2021, v. 81, n. 2, p. 291, doi. 10.1007/s40265-021-01467-4
By:
- Markham, Anthony
Publication type:
Article
Lonafarnib: First Approval.
Published in:
Drugs, 2021, v. 81, n. 2, p. 283, doi. 10.1007/s40265-020-01464-z
By:
- Dhillon, Sohita
Publication type:
Article
Lumasiran: First Approval.
Published in:
Drugs, 2021, v. 81, n. 2, p. 277, doi. 10.1007/s40265-020-01463-0
By:
- Scott, Lesley J.;
- Keam, Susan J.
Publication type:
Article
Evolving Role of Immunotherapy in Metastatic Castration Refractory Prostate Cancer.
Published in:
Drugs, 2021, v. 81, n. 2, p. 191, doi. 10.1007/s40265-020-01456-z
By:
- Rathi, Nityam;
- McFarland, Taylor Ryan;
- Nussenzveig, Roberto;
- Agarwal, Neeraj;
- Swami, Umang
Publication type:
Article
Brigatinib: A Review in ALK-Inhibitor Naïve Advanced ALK-Positive NSCLC.
Published in:
Drugs, 2021, v. 81, n. 2, p. 267, doi. 10.1007/s40265-020-01449-y
By:
- Hoy, Sheridan M.
Publication type:
Article
Lefamulin: A Novel Oral and Intravenous Pleuromutilin for the Treatment of Community-Acquired Bacterial Pneumonia.
Published in:
Drugs, 2021, v. 81, n. 2, p. 233, doi. 10.1007/s40265-020-01443-4
By:
- Zhanel, George G.;
- Deng, Christina;
- Zelenitsky, Sheryl;
- Lawrence, Courtney K.;
- Adam, Heather J.;
- Golden, Alyssa;
- Berry, Liam;
- Schweizer, Frank;
- Zhanel, Michael A.;
- Irfan, Neal;
- Bay, Denice;
- Lagacé-Wiens, Philippe;
- Walkty, Andrew;
- Mandell, Lionel;
- Lynch III, Joseph P.;
- Karlowsky, James A.
Publication type:
Article
Updated Overall Survival in a Randomized Study Comparing Dacomitinib with Gefitinib as First-Line Treatment in Patients with Advanced Non-Small-Cell Lung Cancer and EGFR-Activating Mutations.
Published in:
Drugs, 2021, v. 81, n. 2, p. 257, doi. 10.1007/s40265-020-01441-6
By:
- Mok, Tony S.;
- Cheng, Ying;
- Zhou, Xiangdong;
- Lee, Ki Hyeong;
- Nakagawa, Kazuhiko;
- Niho, Seiji;
- Chawla, Alka;
- Rosell, Rafael;
- Corral, Jesus;
- Migliorino, Maria Rita;
- Pluzanski, Adam;
- Noonan, Kay;
- Tang, Yiyun;
- Pastel, Malaika;
- Wilner, Keith D.;
- Wu, Yi-Long
Publication type:
Article
Sphingosine 1-phosphate Receptor Modulator Therapy for Multiple Sclerosis: Differential Downstream Receptor Signalling and Clinical Profile Effects.
Published in:
Drugs, 2021, v. 81, n. 2, p. 207, doi. 10.1007/s40265-020-01431-8
By:
- Chun, Jerold;
- Giovannoni, Gavin;
- Hunter, Samuel F.
Publication type:
Article
Imeglimin: Current Development and Future Potential in Type 2 Diabetes.
Published in:
Drugs, 2021, v. 81, n. 2, p. 185, doi. 10.1007/s40265-020-01434-5
By:
- Konkwo, Chigoziri;
- Perry, Rachel J.
Publication type:
Article